Printed matter – Method – Identifying
Patent
1988-09-22
1992-04-28
Bell, Paul A.
Printed matter
Method
Identifying
283117, 283116, B42D 1500
Patent
active
051081318
DESCRIPTION:
BRIEF SUMMARY
This invention is concerned with methods of preventing or reducing the risks of transmission of defects from one participant to another, e.g. from one human being to another human being or to an organisation. More particularly it is concerned with such methods of preventing, or substantially reducing the risk of transmission of a communicable disease or disorder. By communicable disease or disorder we include, for example infectious ailments be they viral, bacterial or the like and genetically transmissible disorders.
The invention may find application amongst humans who are contemplating intimate contact or contemplating donation of body fluids or material for reception or use by a second participant. The invention may also be useful to persons or organisations responsible for such donations as blood banks, hospitals, transfusion centers, medical teams and the like. The invention could even be useful in the field of animal husbandry as a means of controlling undesirable disease or disorder under human supervised breeding conditions.
Use of the invention may be a systematic control method to help stop the spread of communicable disease or disorder in which medical treatment is not required. As will become apparent, the invention has a principal application in stemming further spread of sexually communicable diseases amongst humans, notably Acquired Immune Deficiency Syndrome (AIDS) for which there is currently no cure and to a lesser extent, the venereal diseases such as syphilis, gonorrhea or herpes. The invention may also find application in preventing, or substantially reducing the risks of transmission of a genetic disorder from one generation to another e.g. to an offspring of a participant. In this field of hereditary defects the invention may be useful in controlling such communicable defects as, for example, mongolism, cystic fibrosis, haemophilia, diabetes and sickle cell amaemia.
The following terms and expressions are used throughout the description and claims to include the following:
"First Participant": an individual contemplating intimate contact with or donation to a second participant; or a first animal for breeding or donation purposes.
"Defect": communicable disease or disorder being infectious or genetic which may adversely affect the health or function of an individual or animal. The term is used to include any sexually communicable disease amongst living beings, especially AIDS.
"Second Participant": an individual contemplating intimate contact with a user, a second animal for breeding or donation-receiving purposes or an individual, group, team, organisation and the like which receives or monitors donated body fluid or material, or contemplates such receipt.
As examples of body fluid or material that may be donated we include human or animal blood that can be used either immediately or subsequently for transfusion, for conversion into blood products such as separation into blood plasma, or concentration and separation in factor VIII, and e.g. bone marrow for immediate or subsequent transplantation. We also include organs for transplantation, for example, one kidney from an individual (first participant) to a related individual (second participant) when both such individuals are live or posthumous donation of vital organs such as kidneys, heart, lungs in the event of an untimely death of first participant. Individuals wishing to donate any such organs may carry a donor card expressing a wish or preference for a donation or, alternatively, the decision to donate may be made by representatives of the donor, for example, the parents (as second participants in a monitoring function) of an individual recently killed. Before a medical team may wish to use any donated organs they may require up-to-date information in respect of potentially damaging defects such as contamination by the AIDS virus or subject to haemophilia genetic disorder and the like.
As a suitable body fluid which may be donated by individuals or animals we also include semen which may be stored in a sperm bank and used for
REFERENCES:
patent: 3502437 (1970-03-01), Mass
patent: 3921318 (1975-11-01), Calavetta
patent: 4122947 (1978-10-01), Falla
patent: 4236332 (1980-12-01), Domo
patent: 4259391 (1981-03-01), Brecht
patent: 4459015 (1984-07-01), Brecht
patent: 4632428 (1986-12-01), Brown
Bell Paul A.
Mainframe Data Limited
LandOfFree
Method of controlling transmission of defects does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of controlling transmission of defects, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of controlling transmission of defects will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1242754